Ethnic inequities in screening for diabetes in pregnancy in New Zealand-adherence to national guidelines.

AIM The aim of this study was to assess adherence to the 2014 Ministry of Health (MoH) screening guidelines for diabetes in pregnancy (DiP) by Māori and non-Māori in the Waikato region. METHODS Clinical records were reviewed for women without known diabetes before pregnancy who delivered in hospitals or community birth centres in the Waikato region during June-August 2017. Screening rates for DiP were assessed using HbA1c, glucose challenge and/or glucose tolerance tests. RESULTS Of a total of 807 women, 94% received some form of screening for DiP; 527 (65.3%) underwent HbA1c screening at <20 weeks and 267 (33.1%) underwent testing for gestational diabetes at 24-28 weeks' gestation. However, only 213 (26.4%) received all screening as per the MoH guideline. HbA1c testing was the most common screening performed (83.9% of all pregnancies), and three quarters of women had a glucose load screen at some point during pregnancy. In all measures, screening rates were lower in Māori, with only 17.5% (46 of 263 women) receiving both HbA1c and further glucose load screening in the recommended gestation windows (versus 31.6% (171 of 541) for non-Māori; P<0.0005). CONCLUSIONS Adherence to screening guidelines for DiP was poor with a marked ethnic inequity. Further work is needed to investigate the barriers to care that drive these differences.

[1]  C. Wall,et al.  Prevalence of gestational diabetes according to commonly used data sources: an observational study , 2019, BMC Pregnancy and Childbirth.

[2]  Beynon Claire,et al.  Should HbA1C be used to screen pregnant women for undiagnosed diabetes in the first trimester? A review of the evidence. , 2019, Journal of public health.

[3]  D. Simmons,et al.  Screening and Treatment for Early-Onset Gestational Diabetes Mellitus: a Systematic Review and Meta-analysis , 2017, Current Diabetes Reports.

[4]  A. Pillai,et al.  Inequity in timing of prenatal screening in New Zealand: Who are our most vulnerable? , 2017, The Australian & New Zealand journal of obstetrics & gynaecology.

[5]  Chun-Pai Yang,et al.  Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women , 2017, PloS one.

[6]  B. Daly,et al.  Screening for diabetes in pregnancy in a regional area with a high Māori population. , 2017, The New Zealand medical journal.

[7]  M. Agarwal.  Gestational diabetes mellitus: Screening with fasting plasma glucose. , 2016, World journal of diabetes.

[8]  J. Williman,et al.  Universal HbA1c Measurement in Early Pregnancy to Detect Type 2 Diabetes Reduces Ethnic Disparities in Antenatal Diabetes Screening: A Population-Based Observational Study , 2016, PloS one.

[9]  J. Camargo,et al.  HbA1c Test as a Tool in the Diagnosis of Gestational Diabetes Mellitus , 2015, PloS one.

[10]  C. Farquhar,et al.  Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendations , 2015, BMJ Open.

[11]  N. McGrath,et al.  New Zealand National GDM Guidelines: an alternative view of some good practice points , 2015, The Australian & New Zealand journal of obstetrics & gynaecology.

[12]  T. Kenealy,et al.  Impact of using the international association of diabetes and pregnancy study groups criteria in South Auckland: prevalence, interventions and outcomes , 2015, The Australian & New Zealand journal of obstetrics & gynaecology.

[13]  M. Rice,et al.  Mild Gestational Diabetes Mellitus and Long-Term Child Health , 2014, Diabetes Care.

[14]  F. Cram,et al.  Initiation of maternity care for young Maori women under 20 years of age. , 2014, The New Zealand medical journal.

[15]  P. Middleton,et al.  Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A clinical practice guideline , 2014 .

[16]  B. Oldenburg,et al.  Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States: a systematic review of the evidence for screening in early pregnancy , 2013, Diabetes/metabolism research and reviews.

[17]  D. Simmons,et al.  Screening, diagnosis and services for women with gestational diabetes mellitus (GDM) in New Zealand: a technical report from the National GDM Technical Working Party. , 2008, The New Zealand medical journal.

[18]  R. Hanson,et al.  Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. , 2000, Diabetes.

[19]  D. Simmons,et al.  Screening for gestational diabetes mellitus in a multiethnic population in New Zealand. , 2000, Diabetes research and clinical practice.